首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Selection during Cefepime Treatment of a New Cephalosporinase Variant with Extended-Spectrum Resistance to Cefepime in an Enterobacter aerogenes Clinical Isolate
【2h】

Selection during Cefepime Treatment of a New Cephalosporinase Variant with Extended-Spectrum Resistance to Cefepime in an Enterobacter aerogenes Clinical Isolate

机译:头孢吡肟治疗期间新的头孢菌素酶变种对产气肠杆菌临床分离株中头孢吡肟具有广谱耐药性的选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterobacter aerogenes resistant to cefepime (MIC, 32 μg/ml) was isolated from a patient treated with cefepime for an infection caused by a strain of E. aerogenes overproducing its AmpC β-lactamase (MIC of cefepime, 0.5 μg/ml). The AmpC β-lactamase of the resistant strain had an L-293-P amino acid substitution and a high kcat/Km ratio for cefepime. Both of these modifications were necessary for resistance to cefepime.
机译:从头孢吡肟治疗的患者中分离出对头孢吡肟具有抗药性的产气肠杆菌(MIC,32μg/ ml),该菌株是由过度生产其AmpCβ-内酰胺酶的产气链球菌菌株引起的感染(头孢吡肟的MIC,0.5μg/ ml)。耐药菌株的AmpCβ-内酰胺酶具有L-293-P氨基酸取代和头孢吡肟的高kcat / Km比。这两种修饰对于抵抗头孢吡肟都是必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号